A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature-Reference-Cited by-同舟云学术

A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

Published:2015-12 Issue:12 Volume:25 Page:2318-2325
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Zohar Joseph,Stahl Stephen,Moller Hans-Jurgen,Blier Pierre,Kupfer David,Yamawaki Shigeto,Uchida Hiroyuki^ORCID,Spedding Michael,Goodwin Guy M.,Nutt David

Funder

ECNP (Neutoscience-based-Nomenclature)

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference17 articles.

1. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology;Baldwin;J. Psychopharmacol.,2014

2. Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine;Demyttenaere;J. Affect. Disord.,2001

3. A proposed system for classifying psychotropic drugs;Howland;J. Psychosoc. Nurs. Ment. Health Serv.,2014

4. Delineation of two drug-responsive anxiety syndromes;Klein;Psychopharmacologia,1964

5. Second-generation antipsychotics for obsessive compulsive disorder;Komossa;Cochrane Database of Systematic Reviews Issue,2010

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How pharmacology can aid in the diagnosis of mental disorders;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-04

2. What Remains to Be Discovered in Schizophrenia Therapeutics: Contributions by Advancing the Molecular Mechanisms of Drugs for Psychosis and Schizophrenia;Biomolecules;2024-07-25

3. Sex differences among patients with intentional poisoning presenting to the emergency Department at a Tertiary Care Centre in Beirut, Lebanon;Basic & Clinical Pharmacology & Toxicology;2024-07-04

4. We like to move it – patients with schizophrenia spectrum disorders are impaired in estimating their physical fitness levels and benefit from individualized exercise;European Archives of Psychiatry and Clinical Neuroscience;2024-07-02

5. Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment;Clinical Drug Investigation;2024-06-21